Acta Diabetologica

, Volume 51, Issue 5, pp 715–722 | Cite as

Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus?

  • Christian S. Göbl
  • Latife Bozkurt
  • Rajashri Yarragudi
  • Andrea Tura
  • Giovanni Pacini
  • Alexandra Kautzky-WillerEmail author
Original Article


Compared to the 2-h oral glucose tolerance test (OGTT), the assessment of HbA1c was proposed as a less time-consuming alternative to detect pathologies in carbohydrate metabolism. This report aims to assess the predictive accuracy of HbA1c to detect alterations in glucose disposition early after gestational diabetes mellitus (GDM) pregnancy. A detailed metabolic characterization was performed in 77 women with previous GDM (pGDM) and 41 controls 3–6 month after delivery: 3-h OGTT, frequently sampled intravenous glucose tolerance test. Follow-up examinations of pGDMs were performed up to 10 years. HbA1c (venous samples, HPLC) was assessed at baseline as well as during the follow-up period (475 patient contacts). Moderate associations were observed between HbA1c and measurements of plasma glucose during the OGTT at the baseline examination: The strongest correlation was found for FPG (r = 0.40, p < 0.001), decreasing after ingestion. No associations were detected between HbA1c and OGTT dynamics of insulin or C-peptide. Moreover, baseline HbA1c showed only modest correlation with insulin sensitivity (r = −0.25, p = 0.010) and disposition index (r = −0.26, p = 0.007). A linear model including fasting as well as post-load glucose levels was not improved by HbA1c. However, pGDM females with overt diabetes manifestation during the follow-up period showed more pronounced increasing HbA1c in contrast to females remaining normal glucose tolerant or developing prediabetes. It is suggested that the performance of HbA1c assessed early after delivery is inferior to the OGTT for the detection of early alterations in glucose metabolism. However, an increase in HbA1c levels could be used as an indicator of risk for diabetes manifestation.


HbA1c Gestational diabetes mellitus Oral glucose tolerance test Postpartum risk stratification Impaired fasting glucose Impaired glucose tolerance 



We acknowledge to Mrs. Astrid Hofer, Study Nurse, Medical University of Vienna, Department of Internal Medicine III, Mr. Thomas Prikoszovich, MD, Medical University of Vienna, Department of Internal Medicine III, and Mrs. Anita Thomas, Bsc, Department of Internal Medicine III, for helping with data assessment. The study was supported by the Austrian Science Fund (P14515-MED) to AKW.

Conflict of interest

Christian S. Göbl, Latife Bozkurt, Rajashri Yarragudi, Andrea Tura, Giovanni Pacini and Alexandra Kautzky-Willer declare they have no conflict of interest.

Statement of Human and Animal Rights

All procedures followed were in accordance with the ethical standards of the Ethics Committee of the Medical University of Vienna and with the Helsinki Declaration of 1975, as revised in 2008 (5).

Statement of Informed consent

Informed consent was obtained from all patients for being included in the study.

Supplementary material

592_2014_574_MOESM1_ESM.eps (15 kb)
Supplementary material 1 (EPS 1981 kb)
592_2014_574_MOESM2_ESM.pdf (5 kb)
Supplementary material 2 (PDF 4 kb)


  1. 1.
    Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta analysis. Lancet 373:1773–1779PubMedCrossRefGoogle Scholar
  2. 2.
    International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Abdul-Ghani MA, Tripathy D, DeFronzo RA (2006) Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130–1139PubMedCrossRefGoogle Scholar
  4. 4.
    Abdul-Ghani MA, DeFronzo RA (2009) Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care 32:S194–S198PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M (2012) Prediabetes a high-risk state for diabetes development. Lancet 379:2279–2290PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE, Diabetes Prevention Program Research Group (2008) Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrin Metab 93:4774–4779CrossRefGoogle Scholar
  7. 7.
    American Diabetes Association (2010) Standards of medical care in diabetes—2010. Diabetes Care 33:S11–S61CrossRefPubMedCentralGoogle Scholar
  8. 8.
    World Health Organisation (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. World health Organisation, GenevaGoogle Scholar
  9. 9.
    The International Expert Committee (2009) International expert committee report on the role of the A1C Assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Cohen RM, Haggerty S, Herman WH (2010) HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction? J Clin Endocrinol Metab 95:5203–5206PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Kim C, Herman WH, Cheung NW, Gunderson EP, Richardson C (2011) Comparison of haemoglobin A1c with fasting plasma glucose and 2-h postchallenge glucose for risk stratification among women with recent gestational diabetes mellitus. Diabetes Care 34:1949–1951PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Picon MJ, Murri M, Munoz A, Fernandez-Garcia JC, Gomez-Huelgas R, Tinahones FJ (2012) Hemoglobin A1c versus oral glucose tolerance test in postpartum screening. Diabetes Care 35:1648–1653PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D, Pacini G, Funahashi T, Kautzky-Willer A (2004) Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27:1721–1727PubMedCrossRefGoogle Scholar
  14. 14.
    Metzger BE, Coustan DR (1998) The organizing committee: summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care 21(2):161–167Google Scholar
  15. 15.
    Pacini G, Tonolo G, Sambataro M, Maioli M, Ciccarese M, Brocco E, Avogaro A, Nosadini R (1998) Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. Am J Physiol Endocrinol Metab 274:E592–E599Google Scholar
  16. 16.
    Kahn SE, Prigeon RL, McCulloch DSK (2002) Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663–1672CrossRefGoogle Scholar
  17. 17.
    Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548PubMedCrossRefGoogle Scholar
  18. 18.
    Tura A, Kautzky-Willer A, Pacini G (2006) Insulinogenic indices from insulin and C-peptide:comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract 72:298–301PubMedCrossRefGoogle Scholar
  19. 19.
    Göbl CS, Bozkurt L, Prikoszovich T, Winzer C, Pacini G, Kautzky-Willer A (2011) Early possible risk factors for overt diabetes after gestational diabetes mellitus. Obstet Gynecol 118:71–78PubMedCrossRefGoogle Scholar
  20. 20.
    Bozkurt L, Göbl CS, Tura A, Chmelik M, Prikoszovich T, Kosi L, Wagner O, Roden M, Pacini G, Gastaldelli A, Kautzky-Willer A (2012) Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PLoS ONE 7:e32710PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Tura A, Grassi A, Winhofer Y, Guolo A, Pacini G, Mari A, Kautzky-Willer A (2012) Progression to type 2 diabetes in women with former gestational diabetes: time trajectories of metabolic parameters. PLoS ONE 7:e50419PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Göbl CS, Bozkurt L, Prikoszovich T, Tura A, Pacini G, Kautzky-Willer A (2013) Estimating the risk after gestational diabetes mellitus: can we improve the information of the postpartum OGTT? Am J Physiol Endocrinol Metab 304:E524–E530PubMedCrossRefGoogle Scholar
  23. 23.
    Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Müller M (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform 7:77. doi: 10.1186/1471-2105-12-77 CrossRefGoogle Scholar
  24. 24.
    R Core Team (2013). R: a language and environment for statistical computing. R Foundation for Statistical Computing. 6 June 2013
  25. 25.
    Lorenzo C, Wagenknecht LE, Hanley AJ, Rewers MJ, Karter AJ, Haffner SM (2010) A1C between 5.7 and 6.4 % as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes Care 33:2104–2109PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Kanat M, Winnier D, Norton L, Arar N, Jenkinson C, DeFronzo RA, Abdul-Ghani MA (2011) The relationship between β-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study. Diabetes Care 34:1006–1010PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Bianchi C, Miccoli R, Bonadonna RC, Giorgino F, Frontoni S, Faloia E, Marchesini G, Dolci MA, Cavalot F, Cavallo GM, Leonetti F, Del Prato S, GENFIEV Investigators (2012) Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance. Diabetes Care 35:2607–2612PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Ahrén B, Pacini G (2004) Importance of quantifying insulin secretion in relation to insulin sensitivity to accurate assess beta cell function in clinical studies. Eur J Endocrinol 150:97–104PubMedCrossRefGoogle Scholar
  29. 29.
    Kautzky-Willer A, Handisurya A (2009) Metabolic diseases and associated complications: sex and gender matter! Eur J Clin Invest 39:631–648PubMedCrossRefGoogle Scholar
  30. 30.
    Morris DH, Khunti K, Achana F, Srinivasan B, Gray LJ, Davies MJ, Webb D (2013) Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta analysis. Diabetologia 56:1489–1493PubMedCrossRefGoogle Scholar
  31. 31.
    Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Mutner P (2010) Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care 33:2190–2195PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    James C, Bullard KM, Rolka DB, Geiss LS, Williams DE, Cowie CC, Albright A, Gregg EW (2011) Implications of alternative definitions of prediabetes for prevalence in U.S. adults. Diabetes Care 34:387–391PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Lapolla A, Mosca A, Fedele D (2011) The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: still a long way to go. Nutr Metab Cardiovasc Dis 21:467–475PubMedCrossRefGoogle Scholar
  34. 34.
    Seals DR, Hagberg JM, Allen WK, Hurley BF, Dalsky GP, Ehsani AA, Holloszy JO (1984) Glucose tolerance in young and older athletes and sedentary men. J Appl Physiol 56:1521–1525PubMedGoogle Scholar
  35. 35.
    Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E (2007) Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program. Diabetes Care 30:2453–2457PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J, Bouatia-Naji N, Langenberg C, Prokopenko I, Stolerman E, Sandhu MS, Heeney MM, Devaney JM, Reilly MP, Ricketts SL (2010) Common variants at ten genomic loci influence haemoglobin A1C levels via glycemic and non-glycemic pathways. Diabetes 59:3229–3239PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, Palascak MB, Joiner CH (2008) Red cell lifespan heterogeneity in haematologically normal people is sufficient to alter HbA1c. Blood 112:4284–4291PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Hardikar PS, Joshi SM, Bhat DS, Raut DA, Katre PA, Lubree HG, Jere A, Pandit AN, Fall CHD, Yajnik CS (2012) Spuriously high prevalence of prediabetes diagnosed by HbA1c in young Indian partly explained by haematological factors and iron deficiency anemia. Diabetes Care 35:797–802PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Kim C, Bullard KM, Herman WH, Berckles GL (2010) Association between iron deficiency and A1C levels among adults without diabetes in the National Health and Nutrition Survey, 1999–2006. Diabetes Care 33:780–785PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Italia 2014

Authors and Affiliations

  • Christian S. Göbl
    • 1
    • 2
  • Latife Bozkurt
    • 2
  • Rajashri Yarragudi
    • 2
  • Andrea Tura
    • 3
  • Giovanni Pacini
    • 3
  • Alexandra Kautzky-Willer
    • 2
    Email author
  1. 1.Division of Feto-Maternal Medicine, Department of Gynecology and ObstetricsMedical University of ViennaViennaAustria
  2. 2.Unit of Gender Medicine, Division of Endocrinology and Metabolism, Department of Internal Medicine IIIMedical University of ViennaViennaAustria
  3. 3.Metabolic Unit, Institute of Biomedical EngineeringNational Research CouncilPaduaItaly

Personalised recommendations